Maintenance Therapy for Advanced Non–Small-Cell Lung Cancer: A Pilot Study on Patients’ Perceptions
Journal of Thoracic Oncology, 07/17/2012
Peeters L et al. – The pilot survey showed that metastatic Non–Small–Cell Lung Cancer patients in general are in favor of maintenance therapy. They expect either an overall survival benefit of at least several months, or better symptom control, in balance with mild–to–moderate side effects.